Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)

NCT03932786 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT03932786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
January 24, 2019
Completion date
January 31, 2031
Enrollment
900 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

biological sibling, cancer survivor, intraocular retinoblastoma, retinoblastoma, unilateral retinoblastoma